HOME Top Market Reports Sepsis Diagnostics Market by Technology (Molecular Diagnostics, Microbiology, Immunoassay), Product (Instrument, Blood Culture Media), Method (Conventional & Automated), Usability (Laboratory & POC), Pathogen (Bacterial & Fungal) - Global Forecast to 2021

Sepsis Diagnostics Market by Technology (Molecular Diagnostics, Microbiology, Immunoassay), Product (Instrument, Blood Culture Media), Method (Conventional & Automated), Usability (Laboratory & POC), Pathogen (Bacterial & Fungal) - Global Forecast to 2021

By: marketsandmarkets.com
Publishing Date: September 2016
Report Code: MD 4575

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The sepsis diagnostics market is expected to reach USD 564.1 Million by 2021 from USD 370.0 Million in 2016, at a CAGR of 8.8% during the forecast period. Rising geriatric population, growing number of surgical procedures, high incidence of hospital-acquired infections, and increase in the number of product approvals are supporting the growth of this market. However, lack of standard protocols and awareness as well as shortage of skilled staff are the major challenges in this market.

Emerging markets including China and India offer high growth potential for companies engaged in the development and distribution of sepsis diagnostic devices. Growing initiatives by market players, increasing sepsis patient population base, and rising number of partnerships and collaborations among sepsis diagnostic product providers are the key factors propelling the growth of sepsis diagnostics market in the emerging countries.

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the sepsis diagnostics market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each product across the globe. The report provides qualitative insights about growth rates and market drivers for all subsegments. It maps market sizes and growth rates for each subsegment and identifies segments poised for rapid growth in each geographic segment.

bioMιrieux SA (France), T2 Biosystems, Inc. (U.S.), Cepheid (U.S.), Thermo Fisher Scientific Inc. (U.S.), Nanosphere, Inc. (U.S.), Abbott Laboratories, Inc. (U.S.), Roche Diagnostics Limited (Switzerland), Becton, Dickinson and Company (U.S.), Bruker Corporation (U.S.), and Beckman Coulter, Inc. (U.S.) are some of the key players in the sepsis diagnostics market.

Target Audience:

  • Sepsis diagnostic device manufacturing companies
  • Clinical laboratories
  • Hospitals and clinics
  • Research institutes and clinical research organizations (CROs)
  • Market research and consulting firms
  • Sepsis diagnostic devices suppliers and distributors
  • Blood culture media manufacturers
  • Blood culture media distributors and suppliers

To know about the assumptions considered for the study, download the pdf brochure

 Scope of the Report

This research report categorizes the sepsis diagnostics market into the following segments:

Global Sepsis Diagnostics Market, by Technology

  • Microbiology
  • Molecular Diagnostics
  • Immunoassays
  • Flow Cytometry

Global Sepsis Diagnostics Market, by Product

  • Blood Culture Media
  • Instruments
  • Assays & Reagents
  • Software

Global Sepsis Diagnostics Market, by Method

  • Conventional Diagnostics
  • Automated Diagnostics

Global Sepsis Diagnostics Market, by Usability

  • Laboratory Testing
  • Point-of-care Testing

Global Sepsis Diagnostics Market, by Pathogen

  • Bacterial Sepsis
  • Gram-negative Bacterial Sepsis
  • Gram-positive Bacterial Sepsis
  • Fungal Sepsis
  • Others

Global Sepsis Diagnostics Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • Rest of Asia-Pacific
  • Rest of the World

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company‘s specific needs. The following customization options are available for the report:

Technology Analysis

  • Detailed quantitative analysis of the molecular diagnostics technology segment into PCR (polymerase chain reaction), PNA-FISH (peptide nucleic acid-fluorescent in situ hybridization), and microarray

Company Information

  • Detailed analysis and profiling of additional market players (up to five)

Table of Contents

1 Introduction (Page No. - 17)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
    1.4 Markets Covered
           1.4.1 Years Considered for the Study
    1.5 Currency
    1.6 Limitations
    1.7 Stakeholders

2 Research Methodology (Page No. - 20)
    2.1 Research Data
           2.1.1 Secondary Data
                     2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                     2.1.2.1 Key Data From Primary Sources
                     2.1.2.2 Key Industry Insights
           2.1.3 Market Size Estimation Methodology
                     2.1.3.1 Bottom-Up Approach
                     2.1.3.2 Top-Down Approach
           2.1.4 Research Design
           2.1.5 Market Data Validation and Triangulation
           2.1.6 Assumptions for the Study

3 Executive Summary (Page No. - 29)
    3.1 Introduction
    3.2 Current Scenario
    3.3 Future Outlook
    3.4 Conclusion

4 Premium Insights (Page No. - 34)
    4.1 Attractive Market Opportunities in the Global Sepsis Diagnostics
    4.2 Geographic Analysis: Sepsis Diagnostics Market, By Product
    4.3 Sepsis Diagnostics Market Size, By Technology, 2016 vs 2021
    4.4 Sepsis Diagnostics Market Size, By Method and Region, 2016
    4.5 Sepsis Diagnostics Market Size, By USAbility, 2016 vs 2021
    4.6 Sepsis Diagnostics Market Size, By Pathogen, 2016 vs 2021

5 Market Overview (Page No. - 39)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                     5.2.1.1 High Prevalence of Sepsis in the Neonate and Adult Population
                     5.2.1.2 Rising Incidence of Sepsis in Geriatric Population
                     5.2.1.3 Increasing Number of Preterm Births
                     5.2.1.4 Growing Incidence of Hospital-Acquired Infections
                     5.2.1.5 Increasing Number of Surgical Procedures
                     5.2.1.6 Growing Pneumonia Cases
                     5.2.1.7 Influx of Novel Sepsis Diagnostic Products
           5.2.2 Restraints
                     5.2.2.1 High Cost of Automated Diagnostic Devices
                     5.2.2.2 Lack of Established Reimbursement for Sepsis
           5.2.3 Opportunities
                     5.2.3.1 Increasing Funding for Sepsis-Related Research Activities
                     5.2.3.2 Development of Rapid Diagnostic Techniques for Early Sepsis Diagnosis
                     5.2.3.3 Evolution of Procalcitonin Test as A Novel Biomarker for Sepsis Diagnosis
                     5.2.3.4 Rising Initiatives to Increase the Awareness and Drive the Adoption of Sepsis Diagnostic Tests
                     5.2.3.5 Growing Number of Regulatory Approvals for Sepsis Diagnostic Products
           5.2.4 Challenges
                     5.2.4.1 Lack of Standard Protocols and Awareness for Sepsis Diagnosis and Treatment
                     5.2.4.2 Shortage of Skilled Healthcare Professionals

6 Sepsis Diagnostics Market, By Product (Page No. - 49)
    6.1 Introduction
    6.2 Instruments
    6.3 Blood Culture Media
    6.4 Assay Kits & Reagents
    6.5 Software

7 Sepsis Diagnostics Market, By Technology (Page No. - 57)
    7.1 Introduction
    7.2 Microbiology
    7.3 Molecular Diagnostics
    7.4 Immunoassays
    7.5 Flow Cytometry

8 Sepsis Diagnostics Market, By Method (Page No. - 66)
    8.1 Introduction
    8.2 Conventional Diagnostics
    8.3 Automated Diagnostics

9 Sepsis Diagnostics Market, By USAbility (Page No. - 72)
    9.1 Introduction
    9.2 Laboratory Testing
    9.3 Point-Of-Care Testing

10 Sepsis Diagnostics Market, By Pathogen (Page No. - 78)
     10.1 Introduction
     10.2 Bacterial Sepsis
               10.2.1 Gram-Negative Bacterial Sepsis
               10.2.2 Gram-Positive Bacterial Sepsis
     10.3 Fungal Sepsis
     10.4 Other Pathogen Infections

11 Sepsis Diagnostics Market, By Region (Page No. - 86)
     11.1 Introduction
     11.2 North America
               11.2.1 U.S.
                           11.2.1.1 Growing Prevalence of Sepsis
                           11.2.1.2 Increasing Incidences of Hais
                           11.2.1.3 Increasing Government Support for Sepsis Research
                           11.2.1.4 Growing Product Approvals
                           11.2.1.5 Rising Initiatives to Drive the Adoption of Sepsis Diagnostic Tools
                           11.2.1.6 Lack of Standard Protocol for Sepsis Diagnosis Hinders Market Growth
                           11.2.1.7 High Cost of Treatment
               11.2.2 Canada
                           11.2.2.1 Expanding Patient Population Base
                           11.2.2.2 Support for the Development of Novel Sepsis Diagnostic Products
                           11.2.2.3 Growing Focus on Sepsis Management
                           11.2.2.4 Low Awareness Related to Sepsis Management
                           11.2.2.5 Dearth of Training Leading to Inadequate Patient Assessment
     11.3 Europe
               11.3.1 Germany
                           11.3.1.1 High Incidence of Sepsis
                           11.3.1.2 Growing Funding for Sepsis Research
                           11.3.1.3 Initiatives By the German Sepsis Society
                           11.3.1.4 High Awareness Related to the Sepsis Management
                           11.3.1.5 Development of Novel Sepsis Diagnostics Products
                           11.3.1.6 Poor Implementation of Guidelines Related to the Sepsis Management
               11.3.2 U.K.
                           11.3.2.1 Growing Initiatives By Government Organizations
                           11.3.2.2 Increasing Awareness Among Medical Staff and General Practitioners
                           11.3.2.3 Rising Focus Towards the Development of New Sepsis Diagnostics Devices
                           11.3.2.4 Rising Demand for Diagnostic Devices
                           11.3.2.5 Dearth of Paramedics
               11.3.3 France
                           11.3.3.1 Growing Number of Symposiums and Conferences
                           11.3.3.2 High Prevalence of Sepsis
                           11.3.3.3 Growth in Research Funding for Sepsis Diagnosis
               11.3.4 Rest of Europe (RoE)
                           11.3.4.1 Hub for Various Sepsis Related Conferences
                           11.3.4.2 Rapid Growth in the Aging Population
                           11.3.4.3 Initiatives to Diagnose Neonatal Sepsis
                           11.3.4.4 Rising Focus on the Development of Advanced Products
     11.4 Asia-Pacific
               11.4.1 Japan
                           11.4.1.1 Increasing Incidence of Healthcare-Associated Infections
                           11.4.1.2 Growing Aging Population
                           11.4.1.3 Increasing Initiatives By Market Players
                           11.4.1.4 Lack of Proper Reimbursement for Sepsis
               11.4.2 China
                           11.4.2.1 Large Number of Ongoing Clinical Studies
                           11.4.2.2 Developing Healthcare Infrastructure
                           11.4.2.3 Limited Implementation of Surviving Sepsis Campaign (SSC)
               11.4.3 India
                           11.4.3.1 High Sepsis Burden
                           11.4.3.2 Rising Antibiotic Resistance
                           11.4.3.3 Rising Number of Icu Patients
                           11.4.3.4 Increasing Number of Surgical Procedures
                           11.4.3.5 Rising Focus of Local and Global Players
                           11.4.3.6 Shortage of Medical Staff in India
                           11.4.3.7 Lack of Awareness Leading to Death Due to Sepsis
               11.4.4 Rest of Asia-Pacific
                           11.4.4.1 Large Number of Ongoing Conferences
                           11.4.4.2 Rising Initiatives to Increase Awareness About Sepsis
                           11.4.4.3 Significant Patient Population Base in Malaysia
                           11.4.4.4 South Korea Presents Significant Growth Opportunities
                           11.4.4.5 Lack of Established Sepsis Management Guidelines
                           11.4.4.6 Lack of Reimbursement for Sepsis
     11.5 Rest of the World
                           11.5.1.1 Increasing Antibiotic Resistance Among Patients
                           11.5.1.2 Initiatives to Improve Healthcare in Middle East Countries
                           11.5.1.3 High Prevalence of Cancer and Hiv in the Region
                           11.5.1.4 Key Challenges to Market Growth in the Region

12 Competitive Landscape (Page No. - 135)
     12.1 Overview
     12.2 Market Share Analysis
     12.3 Competitive Situation and Trends
               12.3.1 Product Approvals
               12.3.2 Collaborations, Acquisitions, and Partnerships
               12.3.3 New Product Launches
               12.3.4 Other Strategies

13 Company Profiles (Page No. - 141)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     13.1 Introduction
     13.2 Biomιrieux SA
     13.3 Becton, Dickinson and Company
     13.4 Thermo Fisher Scientific Inc.
     13.5 Abbott Laboratories, Inc.
     13.6 Roche Diagnostics Limited (A Subsidiary of F. Hoffmann-La Roche Ltd.)
     13.7 Cepheid Inc.
     13.8 T2 Biosystems, Inc.
     13.9 Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation)
     13.10 Nanosphere, Inc. (A Luminex Company)
     13.11 Bruker Corporation

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 165)
     14.1 Discussion Guide
     14.2 Other Developments
     14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.4 Introducing RT : Real-Time Market Intelligence
     14.5 Available Customizations
     14.6 Related Reports


List of Tables (100 Tables)

Table 1 Sepsis Diagnostics Market Size, By Product, 2014-2021 (USD Million)
Table 2 Sepsis Diagnostic Instruments Market Size, By Region, 2014-2021 (USD Million)
Table 3 Blood Culture Media Market Size, By Region, 2014-2021 (USD Million)
Table 4 Assay Kits & Reagents Market Size, By Region, 2014-2021 (USD Million)
Table 5 Software Market Size, By Region, 2014-2021 (USD Million)
Table 6 Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 7 Microbiology Market Size, By Region, 2014–2021 (USD Million)
Table 8 Molecular Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 9 Immunoassays Market Size, By Region, 2014–2021 (USD Million)
Table 10 Flow Cytometry Market Size, By Region, 2014–2021 (USD Million)
Table 11 Sepsis Diagnostics Market Size, By Method, 2014-2021 (USD Million)
Table 12 Conventional Diagnostics Market Size, By Region, 2014-2021 (USD Million)
Table 13 Automated Diagnostic Market Size, By Region, 2014–2021 (USD Million)
Table 14 Sepsis Diagnostics Market Size, By Usability, 2014-2021 (USD Million)
Table 15 Parameters Tested in Sepsis Diagnosis
Table 16 Laboratory Testing Market Size, By Region, 2014-2021 (USD Million)
Table 17 Point-Of-Care Testing Market Size, By Region, 2014-2021 (USD Million)
Table 18 Sepsis Diagnostics Market Size, By Pathogen, 2014-2021 (USD Million)
Table 19 Bacterial Sepsis Market Size, By Type, 2014-2021 (USD Million)
Table 20 Bacterial Sepsis Market Size, By Region, 2014-2021 (USD Million)
Table 21 Fungal Sepsis Market Size, By Region, 2014-2021 (USD Million)
Table 22 Other Pathogen Infections Market Size, By Region, 2014-2021 (USD Million)
Table 23 Sepsis Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 24 North America: Sepsis Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 25 North America: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 26 North America: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 27 North America: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 28 North America: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 29 North America: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 30 U.S.: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 31 U.S.: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 32 U.S.: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 33 U.S.: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 34 U.S.: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 35 Canada: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 36 Canada: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 37 Canada: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 38 Canada: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 39 Canada: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 40 Europe: Sepsis Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 41 Europe: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 42 Europe: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 43 Europe: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 44 Europe: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 45 Europe: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 46 Germany: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 47 Germany: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 48 Germany: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 49 Germany: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 50 Germany: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 51 U.K.: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 52 U.K.: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 53 U.K.: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 54 U.K.: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 55 U.K.: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 56 France: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 57 France: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 58 France: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 59 France: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 60 France: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 61 RoE: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 62 RoE: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 63 RoE: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 64 RoE: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 65 RoE: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 66 APAC: Sepsis Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 67 APAC: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 68 APAC: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 69 APAC: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 70 APAC: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 71 APAC: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 72 Japan: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 73 Japan: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 74 Japan: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 75 Japan: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 76 Japan: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 77 China: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 78 China: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 79 China: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 80 China: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 81 China: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 82 India: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 83 India: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 84 India: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 85 India: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 86 India: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 87 RoAPAC: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 88 RoAPAC: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 89 RoAPAC: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 90 RoAPAC: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 91 RoAPAC: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 92 RoW: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 93 RoW: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 94 RoW: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 95 RoW: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 96 RoW: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 97 Top 5 Product Approvals, 2013–2016
Table 98 Top 5 Collaborations, Acquisition, and Partnerships, 2013–2016
Table 99 Top 4 New Product Launches, 2013–2016
Table 100 Top 5 Other Strategies, 2013–2016
 
 
List of Figures (58 Figures)
 
Figure 1 Sepsis Diagnostics Market Segmentation
Figure 2 Global Sepsis Diagnostics Market: Research Methodology Steps
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Global Sepsis Diagnostics Market, By Product, 2016
Figure 7 Global Sepsis Diagnostics Market, By Technology, 2016 (USD Million)
Figure 8 Global Sepsis Diagnostics Market, By Method, 2016 vs 2021
Figure 9 Global Sepsis Diagnostics Market, By Usability, 2016 vs 2021
Figure 10 Global Sepsis Diagnostics Market, By Pathogen, 2016 vs 2021
Figure 11 Global Sepsis Diagnostics Market, By Region, 2016 (USD Million)
Figure 12 Increasing Prevalence of Sepsis—Primary Driver of the Sepsis Diagnostics Market
Figure 13 Blood Culture Media Segment to Dominate the Global Sepsis Diagnostics Market in 2016
Figure 14 Microbiology Segment Will Continue to Dominate the Sepsis Diagnostics Market in 2021
Figure 15 Conventional Diagnostics Segment to Dominate the Global Sepsis Diagnostics Market in 2016
Figure 16 Laboratory Testing Segment to Dominate the Global Sepsis Diagnostics Market in 2016
Figure 17 Bacterial Sepsis Segment to Dominate the Global Sepsis Diagnostics Market in 2016
Figure 18 Sepsis Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Chances of Developing Sepsis Increase With Age, 2014
Figure 20 Patient Survival Rate in Sepsis Cases
Figure 21 Blood Culture Media Segment to Witness Higher Growth During the Forecast Period (2016- 2021)
Figure 22 North America to Dominate the Instruments Market in 2016
Figure 23 Asia-Pacific to Witness Highest Growth in the Blood Culture Media Market, 2016
Figure 24 North America to Dominate the Assay Kits & Reagents Market in 2016
Figure 25 Asia-Pacific to Witness Highest Growth in the Software Segment (2016-2021)
Figure 26 Molecular Diagnostics Segment to Witness High Growth During the Forecast Period (2016-2021)
Figure 27 North America to Dominate the Microbiology Market in 2016
Figure 28 Asia-Pacific to Witness Highest Growth in the Molecular Diagnostics Market in 2016
Figure 29 North America to Dominate the Immunoassays Market in 2016
Figure 30 North America to Dominate the Flow Cytometry Market in 2016
Figure 31 Conventional Diagnostics Segment Will Continue to Dominate the Sepsis Diagnostics Market in 2021
Figure 32 North America to Dominate the Conventional Diagnostics Market in 2016
Figure 33 Asia-Pacific to Witness High Growth in the Automated Diagnostics Segment During the Forecast Period, 2016-2021
Figure 34 POCT Segment to Witness Highest Growth During the Forecast Period, 2016-2021
Figure 35 North America to Dominate the Laboratory Testing Market in 2016
Figure 36 Asia-Pacific to Witness Highest Growth in the Point-Of-Care Testing Segment (2016-2021)
Figure 37 Bacterial Sepsis Segment to Witness Highest Growth, 2016–2021
Figure 38 Gram-Negative Bacteria Segment to Dominate the Bacterial Sepsis Market in 2016
Figure 39 Asia-Pacific to Witness Higher Growth During the Forecast Period, (2016-2021)
Figure 40 North America to Dominate the Fungal Sepsis Market in 2016
Figure 41 Asia-Pacific to Witness Highest Growth in the Other Pathogens Segment in 2016
Figure 42 Sepsis Diagnostics Market: Growth Forecast, By Region (2016–2021)
Figure 43 North America: Sepsis Diagnostics Market Snapshot
Figure 44 Europe: Sepsis Diagnostics Market Snapshot
Figure 45 APAC: Sepsis Diagnostics Market Snapshot
Figure 46 Global Sepsis Diagnostics Market Share Analysis, By Key Player, 2015
Figure 47 Battle for Market Share: Product Approvals the Key Strategy
Figure 48 Geographic Revenue Mix of the Top Players
Figure 49 Biomιrieux Sa: Company Snapshot
Figure 50 Becton, Dickinson and Company: Company Snapshot
Figure 51 Thermo Fisher Scientific Inc.: Company Snapshot
Figure 52 Abbott Laboratories, Inc.: Company Snapshot
Figure 53 Roche Diagnostics Limited: Company Snapshot
Figure 54 Cepheid: Company Snapshot
Figure 55 T2 Biosystems, Inc.: Company Snapshot
Figure 56 Danaher Corporation: Company Snapshot
Figure 57 Luminex Corporation: Company Snapshot
Figure 58 Bruker Corporation: Company Snapshot 

The global sepsis diagnostics market is expected to reach USD 564.1 Million by 2021 from USD 370.0 Million in 2016, growing at a CAGR of 8.8% between 2016 and 2021.

On the basis of products, the global sepsis diagnostics market is segmented into 4 broad categories, namely, blood culture media, assay kits & reagents, instruments, and software. The blood culture media market is estimated to command the largest share of the global sepsis diagnostics market in 2016. The large share of this segment can be attributed to the high use of blood culture testing as the standard diagnostic method for the diagnosis and identification of sepsis. The global assay kits & reagents segment, on the other hand, is expected hold the second largest share in the sepsis diagnostics market. Increasing adoption of assay based kits and growing approvals for assay kit products across the globe is fueling the growth of the assay kits & reagents market.

On the basis of technology, the market is segmented into four major technologies, namely, microbiology, immunoassays, molecular diagnostics, and flow cytometry. The microbiology segment holds the largest share in the sepsis diagnostics market and is expected to grow at a high CAGR during the forecast period. The global molecular diagnostic segment is expected to grow at the highest CAGR from 2016 to 2021. Its growth can be attributed to the increasing inclination of physicians and patients towards use of rapid diagnostic products for accurate and quick identification and diagnosis of sepsis.

The sepsis diagnostics market is categorized into two segments, namely, conventional diagnostics and automated diagnostics. The conventional diagnostics segment is estimated to command the larger share of the global sepsis diagnostics market in 2016. The growth of this segment can be attributed to the high adoption of this method for sepsis diagnosis, due to the ease, and presence of long-term/established clinical evidences.

On the basis of usability, the sepsis diagnostics market is further segmented into laboratory testing and point-of-care testing. The laboratory testing segment is expected to account for a larger share of the sepsis diagnostics market in 2016. The large share of this segment can be attributed to the high use of conventional blood culture tests for sepsis diagnosis, lack of awareness about POC sepsis diagnosis devices, and low cost of laboratory testing services.

The sepsis diagnostics market on the basis of pathogen is segmented into bacterial sepsis, fungal sepsis, and other infectious pathogens (viral and parasitic infection). The bacterial sepsis segment is expected to account for a larger share of the sepsis diagnostics market in 2016.

On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia-Pacific, and Rest of the World. In 2016, the global sepsis diagnostics market is estimated to be dominated by North America. A number of factors such as high prevalence of sepsis, rising number of invasive procedures, growing adoption of high-end sepsis diagnostics devices, and rising government support towards sepsis researches are driving the growth of the North American sepsis diagnostics market. The Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. Factors such as increasing number of surgical procedures, growing number of clinical studies, developing healthcare infrastructure, and rising focus of global players are the key factors stimulating the growth of the sepsis diagnostics market in the Asia-Pacific nations are propelling the growth of the sepsis diagnostics market. In the region

Sepsis Diagnostics Market

bioMιrieux SA (France), T2 Biosystems, Inc. (U.S.), Cepheid (U.S.), Thermo Fisher Scientific Inc. (U.S.), Nanosphere, Inc. (U.S.), Abbott Laboratories, Inc. (U.S.), Roche Diagnostics Limited (Switzerland), Becton, Dickinson and Company (U.S.), Bruker Corporation (U.S.), and Beckman Coulter, Inc. (U.S.) are some of the key players operating in the global sepsis diagnostics market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth In-Vitro Diagnostics Markets on KnowledgeStore
Request Demo